medication-access
(8)
Forus
Forus is a New York-based healthtech company (formerly Tandem Technology, Inc.) that runs an AI-powered network connecting doctors, pharmacies, payers, and biopharma to get prescribed medications to patients faster. Its software embeds in physician workflows and automates the administrative steps between a clinical decision and a patient starting treatment - prior authorization, benefit verification, financial assistance, and pharmacy routing. Free for doctors and patients, Forus earns revenue through pharmaceutical partnerships. Founded in 2023 by former Oscar Health product leader Sahir Jaggi, the company reached a reported $1 billion valuation in May 2026 with backing from Thrive Capital, General Catalyst, and Accel.
Develop Health
Develop Health is a San Francisco Bay Area healthtech company building AI that removes the paperwork between a doctor writing a prescription and a patient actually getting it. Its EHR-integrated platform uses more than a dozen purpose-built large language model pipelines to verify insurance coverage in real time, assemble and submit the correct prior authorization package, track status, and draft appeals for denials - work that normally consumes hours of a care team's day. Founded in 2022 by former Canvas Medical and Rupa Health operators, the company raised a $14.3M Series A in August 2025 and says it cuts medication-access admin work by roughly 83% while supporting hundreds of thousands of patients a month.
Lamar Health
Lamar Health is a San Francisco software company that automates the paperwork behind expensive specialty medications. Its AI-driven platform handles unified intake, insurance verification, clinical and payor requirement checks, and prior authorization submission and tracking for specialty pharmacies, infusion clinics, and home infusion pharmacies - the drugs that average around $70,000 per patient per year. Founded by Ph.D. geneticist Eesha Sharma and backed by Y Combinator (W21), Lamar aims to get patients on therapy in days instead of weeks without forcing providers to add headcount.
PARx Solutions
PARx Solutions is a Burlington, Massachusetts healthcare technology and services company that untangles one of medicine's most frustrating chores: prior authorization. Its Prior Authorization Support System (PASS) pairs a secure web portal with a call center of healthcare and reimbursement specialists who handle the paperwork and back-and-forth with health plans on a prescriber's behalf. Because the service is sponsored by drug manufacturers, it is free to physician offices and pharmacies, and it helps patients actually get the medications their doctors prescribed rather than abandoning treatment in the administrative maze.
PrescriberPoint
PrescriberPoint is a Boston-based, AI-enabled point-of-care platform that supports clinicians at every step of the prescribing journey - from researching FDA-approved drug information to checking coverage and out-of-pocket costs, submitting prior authorizations, and enrolling patients in savings programs. Spun out of work with Eli Lilly and BCG, it consolidates fragmented prescribing resources for tens of thousands of medications into one portal, and in 2025 reached more than 5 million healthcare professionals - one of the largest active HCP networks in digital health.
Dan Cornwell
Dan Cornwell is the founder and CEO of PrescriberPoint, a Boston-based, AI-enabled medication access platform that helps clinicians cut through the paperwork between writing a prescription and a patient actually getting their medicine. Spun out of Eli Lilly in partnership with BCG Digital Ventures, the company raised seed backing from an unusual coalition of would-be rivals - Lilly, Pfizer, Adobe and Mastercard. Before PrescriberPoint, Cornwell ran the nurse-staffing marketplace IntelyCare and advised companies on building disruptive businesses at BCG Digital Ventures. A Yale historian turned Wharton-trained operator, he keeps returning to the same problem: the messy gap between a good intention and a completed transaction.
BlinkRx
BlinkRx is the enterprise platform of New York-based Blink Health, founded by brothers Geoffrey and Matthew Chaiken. Billed as a 'pharma-to-patient cloud,' it lets pharmaceutical manufacturers run the entire prescription journey - pricing, prior authorization, copay assistance, fulfillment, free home delivery, and adherence support - on a single system. Its consumer side offers cash-pay discounts and an online pharmacy. The company says it supports millions of patients across all 50 states and has raised hundreds of millions in venture funding.
Geoffrey Chaiken
Geoffrey Chaiken is the co-founder and CEO of BlinkRx (Blink Health), a New York-based digital health company rebuilding how prescription drugs get priced, paid for, and delivered. The son and grandson of physicians, he gave up a career in medicine to attack what he calls the real bottleneck in healthcare - not discovering new cures, but getting existing ones into patients' hands at a fair price. With his younger brother Matthew, he has raised more than half a billion dollars to digitize both the patient front end and the pharmaceutical industry's back end, partnering with drug makers and tens of thousands of pharmacies to strip middlemen out of the medication supply chain.